May 18, 2017 11:01 am UTC| Business
ATLANTA, May 18, 2017 -- A Canadian utility will soon launch Apogee Interactive’s Energy Advisor for its residential customers and Apogee’s Commercial Energy Calculator for business customers, proven industry-leading...
May 18, 2017 11:01 am UTC| Business
ATLANTA, May 18, 2017 -- A Canadian utility will soon launch Apogee Interactive’s Energy Advisor for its residential customers and Apogee’s Commercial Energy Calculator for business customers, proven industry-leading...
May 18, 2017 11:00 am UTC| Business
SAINT-GENIS-POUILLY, France, May 18, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that it will...
Atlas Air Worldwide Prices Convertible Senior Notes
May 18, 2017 10:55 am UTC| Business
PURCHASE, N.Y., May 18, 2017 -- Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) today announced the pricing of $260.0 million aggregate principal amount of its 1.875% convertible senior notes due 2024 in an...
Perry Ellis International Reports First Quarter Fiscal 2018 Results
May 18, 2017 10:45 am UTC| Business
MIAMI, May 18, 2017 -- Perry Ellis International, Inc. (NASDAQ:PERY) today reported results for the first quarter ended April 29, 2017 (“first quarter of fiscal 2018”). Key Fiscal First Quarter 2018 Financial...
May 18, 2017 10:32 am UTC| Business
NEWTON, Mass., May 18, 2017 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that interim clinical data from the ongoing Phase 2b SADAL study evaluating lead...
ObsEva Announces the Completion of a Phase 1 Drug-Drug Interaction Study with OBE022
May 18, 2017 10:32 am UTC| Business
- OBE022 is ObsEva's potential first-in-class, oral and selective PGF2alpha receptor antagonist for the treatment of preterm labor - Geneva, Switzerland and Boston, MA - 18 May 2017 - ObsEva SA (Nasdaq: OBSV), a...
India's 2025 Trade Push: Major FTAs & Global Partnerships Secured